Christopher Buskirk - 14 Jul 2025 Form 4 Insider Report for COLOMBIER ACQUISITION CORP. II (CLBR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 Jul 2025, 20:00:55 UTC
Prior SEC filing
20 Nov 2023
Next SEC filing
03 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christopher Buskirk

Key filing fact

Christopher Buskirk filed Form 4 for COLOMBIER ACQUISITION CORP. II (CLBR) on 17 Jul 2025.

Key facts

  • This page summarizes Christopher Buskirk's Form 4 filing for COLOMBIER ACQUISITION CORP. II (CLBR).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 17 Jul 2025, 20:00.

Change

  • Previous filing in this sequence was filed on 20 Nov 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002001044 Primary reporting owner

Buskirk Christopher

Relationship
Director
Address
214 BRAZILIAN AVENUE, SUITE, 200-J, PALM BEACH
Signature
/s/ Christopher Buskirk
Signature date
17 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLBRU transaction

Class A Ordinary Shares

Other

Transaction value
Shares
+17,250
Change %
Price
Shares after
17,250
Date
14 Jul 2025
Ownership
Direct
Footnotes
F1
CLBRU transaction

Class A Ordinary Shares

Other

Transaction value
Shares
+500,000
Change %
Price
Shares after
500,000
Date
14 Jul 2025
Ownership
See Footnote
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CLBRU transaction Derivative

Warrants

Other

Transaction value
$0
Shares
-1,250,000
Change %
-50%
Price
$0.000000
Shares after
1,250,000
Date
14 Jul 2025
Ownership
See Footnote
Underlying class
Class A Ordinary Shares
Underlying amount
1,250,000
Exercise price
$11.50
Footnotes
F1, F3, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents shares or warrants received for no consideration in connection with a pro rata distribution of Issuer securities held by Colombier Sponsor II LLC (the "Sponsor") to its members.

Footnote F2

Represents 100,000 shares beneficially owned for the benefit of the Reporting Person indirectly by Anabasis VI, LLC, and 400,000 shares owned by 1789 Capital Fund I, LP, an entity over which the Reporting Person exercises voting, investment and dispositive power. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

Footnote F3

Exercisable on a date commencing 30 days after the completion of the Issuer's initial business combination.

Footnote F4

Expire on a date that is five years after the completion of the Issuer's initial business combination.

Footnote F5

Represents (i) 250,000 warrants beneficially owned for the benefit of the Reporting Person indirectly by Anabasis VI, LLC, and (ii) 1,000,000 warrants owned by 1789 Capital Fund I, LP. an entity over which the Reporting Person exercises voting, investment and dispositive power. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .